Person

Michael Groessl

This person is no longer with EPFL

Related publications (22)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Michael Groessl

Graph Chatbot

Chat with Graph Search

Ligand substitutions between ruthenium-cymene compounds can control protein versus DNA targeting and anticancer activity

Application of mass spectrometric techniques to delineate the modes-of-action of anticancer metallodrugs

Synthesis and characterization of a new class of anti-angiogenic agent based on ruthenium clusters

Anthracene-Tethered Ruthenium(II) Arene Complexes as Tools To Visualize the Cellular Localization of Putative Organometallic Anticancer Compounds

Maleimide-functionalised organoruthenium anticancer agents and their binding to thiol-containing biomolecules

Combination of metallomics and proteomics to study the effects of the metallodrug RAPTA-T on human cancer cells

Multinuclear Cytotoxic Metallodrugs: Physicochemical Characterization and Biological Properties of Novel Heteronuclear Gold-Titanium Complexes

Mass Spectrometric and Theoretical Study of Polyiodides: The Connection between Solid State, Solution, and Gas Phases

Cellular uptake and subcellular distribution of ruthenium-based metallodrugs under clinical investigation versus cisplatin

Metal-Based Inhibition of Poly(ADP-ribose) Polymerase - The Guardian Angel of DNA